Interestingly, here we also provide evidence that the exogenous addition of sKl to SSc-MVECs might improve the formation of the aforementioned complex through the downregulation of VEGF165b and the parallel upregulation of TRPC-1 with a consequent boost of the angiogenic response. The gene discussed is TRPC1; the disease is systemic sclerosis.